Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The purpose of this two-year extension is to allow patients who have completed the one-year core study to continue treatment with FTY720 or MMF in combination with reduced or full-dose Neoral (per randomized treatment assignment) beyond the first year post-transplantation for a total of three years follow-up.
Inclusion criteria
- Prophylaxis of kidney allograft rejection in de novo adult renal transplant recipients